ARTICLE | Clinical News
Oral neratinib: Phase III data
July 28, 2014 7:00 AM UTC
Top-line data from the double-blind, international Phase III ExteNET trial in 2,821patients with early stage HER2-positive breast cancer who had undergone surgery and adjuvant treatment with Hercepti...